Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Brain Behav Immun. 2016 Oct 5;61:14–20. doi: 10.1016/j.bbi.2016.09.025

Figure 2.

Figure 2

Antibody persistence model estimates with p values from simple main effect decomposition of the interaction between CMV serostatus (seronegative − /seropositive +) and beta-blocker use (on + /off −). Each bar represents the estimated spring antibody titer (in approximate Z units, or the number of standard deviations from the mean = 0) for each combination of CMV serostatus and beta-blocker use. Each bar starts at 0 and extends to the approximate Z unit for the designated combination. Error bars represent standard errors of the estimates.